
Multi-Drug Rapid Test 1-Step Cup
Methylenedioxymethamphetamine
(MDMA )
d,l-Methylenedioxymethamphetamine
Tricyclic Antidepressants (TCA)
2-ethylidene-1,5-dimethyl3,3-diphenylpyrrolidine (EDDP)
2-ethylidene-1,5-dimethyl3,3-diphenylpyrrolidine
6-mono-aceto-morphine (6-MAM)
(±) 3,4-MethylenedioxyAmphetamine (MDA)
(±) 3,4-MethylenedioxyAmphetamine
Ethyl- β-D-Glucuronide (ETG)
Lysergic Acid Diethylamide (LSD)
Lysergic Acid Diethylamide
7-Aminoclonazepam (7-ACL)
3, 4-methylenedioxypyrovalerone
(MDPV)
3, 4-methylenedioxy
pyrovalerone
α-Pyrrolidinovalerophenone (α-PVP )
α-Pyrrolidinovalerophenone
N,N-Dimethyltryptamine (NND)
Buffers and non-reactive ingredients
With/Without Adulteration (Urine)
Package Insert
Instruction Sheet for testing of any combination of the following drugs:
ACE/AMP/BAR/BZO/BUP/COC/THC/MTD/MET/MDMA/MOP/MQL/OPI/PCP/PPX/TCA/TML/
KET/OXY/COT/EDDP/FYL/K2/6-MAM/MDA/ETG/CLO/LSD/MPD/ZOL/DIA/ZOP/MCAT/7-ACL
/CFYL/C AF/CAT/TRO/MDPV/MEP/ALP/ABP/ α-PVP/ CNB/MPRD/PGB/ TZD/UR-144/ZAL/
MES/GAB/TLD/QTP/PAP/KRA/CAR/FLX/CIT/FKET/OZP/RPD/TAP/NND/SCOP/MTZ/ALC
Including Specimen Validity Tests (S.V.T.) for:
Oxidants/PCC, Specific Gravity, pH, Nitrite, Glutaraldehyde, Creatinine and Bleach
A rapid test for the simultaneous, qualitative detection of multiple drugs and drug metabolites in
human urine. For healthcare professionals including professionals at point of care sites.
Immunoassay for in vitro diagnostic use only.
【INTENDED USE AND SUMMARY】
The Multi-Drug Rapid Test is a rapid chromatographic immunoassay for the qualitative detection
of multiple drugs and drug metabolites in urine at the following cut-off concentrations that can be
performed with the use of the Cup Reader.
Configurations of the Multi-Drug Rapid Test come with any combination of the above listed drug
analytes with or without S.V.T. This assay provides only a preliminary analytical test result. A
more specific alternate chemical method must be used in order to obtain a confirmed analytical
result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method.
Clinical consideration and professional judgment should be applied to any drug of abuse test
result, particularly when preliminary positive results are indicated.
【SUMMARY OF ADULTERATION】
Adulteration is the tampering of a urine specimen with the intention of altering the test results.
The use of adulterants can cause false negative results in drug tests by either interfering with
the screening test and/or destroying the drugs present in the urine. Dilution may also be
employed in an attempt to produce false negative drug test results.
One of the best ways to test for adulteration or dilution is to determine certain urinary
characteristics such as pH, specific gravity and creatinine and to detect the presence of
oxidants/PCC, nitrites or glutaraldehyde in urine.
【PRINCIPLE (FOR DOA TESTS EXCLUDING ALCOHOL)】
During testing, a urine specimen migrates upward by capillary action. A drug, if present in the
urine specimen below its cut-off concentration, will not saturate the binding sites of its specific
antibody. The antibody will then react with the drug-protein conjugate and a visible colored line
will show up in the test region of the specific drug dipstick. The presence of drug above the
cut-off concentration will saturate all the binding sites of the antibody. Therefore, the colored
line will not form in the test region.
A drug-positive urine specimen will not generate a colored line in the specific test region of the
dipstick because of drug competition, while a drug-negative urine specimen will generate a line
in the test region because of the absence of drug competition.
To serve as a procedural control, a colored line will always appear at the control region,
indicating that proper volume of specimen has been added and membrane wicking has
occurred.
【PRINCIPLE OF ADULTERATION】
Oxidants/PCC (Pyridiniumchlorochromate) tests for the presence of oxidizing agents such
as bleach and hydrogen peroxide. Pyridiniumchlorochromate (sold under the brand name Urine
Luck) is commonly used adulterant.1 Normal human urine should not contain oxidants of PCC.
Specific gravity tests for sample dilution. The normal range is from 1.003 to 1.030. Values
outside this range may be the result of specimen dilution or adulteration.
pH tests for the presence of acidic or alkaline adulterants in urine. Normal pH levels should be in
the range of 4.0 to 9.0. Values outside of this range may indicate the sample has been altered.
Nitrite tests for commonly used commercial adulterants such as Klear and Whizzies. They work
by oxidizing the major cannabinoid metabolite THC-COOH.2 Normal urine should contain no
trace of nitrite. Positive results generally indicate the presence of an adulterant.
Glutaraldehyde tests for the presence of an aldehyde. Adulterants such as Urin Aid and Clear
Choice contain glutaraldehyde which may cause false negative results by disrupting the enzyme
used in some immunoassay tests.2 Glutaraldehyde is not normally found in urine; therefore,
detection of glutaraldehyde in a urine specimen is generally an indicator of adulteration.
Creatinine is a waste product of creatine; an amino-acid contained in muscle tissue and found
in urine.3 A person may attempt to foil a test by drinking excessive amounts of water or diuretics
such as herbal teas to “ flush” the system. Creatinine and specific gravity are two ways to check
for dilution and flushing, which are the most common mechanisms used in an attempt to
circumvent drug testing. Low Creatinine and specific gravity levels may indicate dilute urine. The
absence of Creatinine (<5 mg/dL) is indicative of a specimen not consistent with human urine.
Bleach tests for the presence of bleach bleach refers to a number of chemicals which
remove color, whiten or disinfect, often by oxidation, Bleaches are used as household
chemicals to whiten clothes and remove stains and as disinfectants. Normal human urine
should not contain bleach.
【PRINCIPLE (FOR ALCOHOL)】
The urine Alcohol Rapid Test consists of a plastic strip with a reaction pad attached at the tip.
On contact with alcohol, the reaction pad will change colors depending on the concentration of
alcohol present. This is based on the high specificity of alcohol oxidase for ethyl alcohol in the
presence of peroxidase and enzyme substrate such as TMB.
【REAGENTS (FOR DOA TESTS EXCLUDING ALCOHOL)】
Each test line contains anti-drug mouse monoclonal antibody and corresponding drug-protein
conjugates. The control line contains goat anti-rabbit IgG polyclonal antibodies and rabbit IgG.
【REAGENTS (FOR ALCOHOL)】
Tetramethylbenzidine /Alcohol Oxidase/Peroxidase
【S.V.T REAGENTS】
【PRECAUTIONS】
For healthcare professionals including professionals at point of care sites.
Immunoassay for in vitro diagnostic use only. The test should remain in the sealed pouch
until use.
All specimens should be considered potentially hazardous and handled in the same manner
as an infectious agent.
The used test should be discarded according to local regulations.
For use exclusively with the Cup Reader. Do not interpret test results visually.
【STORAGE AND STABILITY】
Store as packaged in the sealed pouch at 2-30 °C. The test is stable through the expiration date
printed on the sealed pouch. The Test Cup must remain in the sealed pouch until use. DO NOT
FREEZE. Do not use beyond the expiration date.
【SPECIMEN COLLECTION AND PREPARATION】
The urine specimen should be collected in a clean and dry container. Urine collected at any
time of the day may be used. Urine specimens exhibiting visible precipitates should be
centrifuged, filtered, or allowed to settle to obtain a clear specimen for testing.
Urine specimens may be stored at 2-8 °C for up to 48 hours prior to testing. For prolonged
storage, specimens may be frozen and stored below -20 °C. Frozen specimens should be
thawed and mixed well before testing. When testing cards with S.V.T. or Alcohol storage of
urine specimens should not exceed 2 hours at room temperature or 4 hours refrigerated prior to
testing.
【MATERIALS】
Materials Required But Not Provided
【DIRECTIONS FOR USE】
Allow the test, urine specimen, and/or controls to reach room temperature (15-30 ºC)
prior to testing.
1. Bring the pouch to room temperature before opening it. Remove the cup from the sealed
pouch and use it within 1 hour.
2. Donor provides specimen.
3. Technician replaces and secures cap while the cup is on a flat surface.
4. Check the temperature label (Temp Label) up to 4 minutes after specimen collection. A
green color will appear to indicate the temperature of the urine specimen. The proper range
for an unadulterated specimen is 32-38 °C (90-100 °F).
5. Technician dates and initials the security seal and attaches the security seal over the cup
cap.
6. Technician peels off the label on the multi-drug test cup to read results.
7. Put the cup into cup reader detection chamber at 5 min and close the chamber cap to
read the results by the cup reader. Do not read the test results visually.
Refer to your Drug Free Policy for guidelines on adulterated specimens. We recommend not
interpreting the drug test results and either retest the urine or collect another specimen in
case of any positive result for any adulteration test.
Note: For the Installation, startup, system calibration and complete test operations of the cup
reader, please refer to the Cup Reader User Manual carefully. Operator must consult the
Cup Reader User Manual prior to use and become familiar with the operations and
quality control procedures.
Urine Assay
Specimen Storage
Materials Provided
1/ 6

【INTERPRETATION OF DOA RESULTS】
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + - + 0% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30 0 -50% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30 0 +300% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + - + 0% Cut-off
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + -
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30 0 -50% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30 0 +300% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + - + 0% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30 0 +300% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + -
Results read by Cup Reader
The result of positive or negative for each analyte is determined by the Cup Reader.
Results Example:
NEGATIVE:This negative result means that the concentrations in the urine sample are below
the designated cut-off levels for a particular drug tested.
POSITIVE: The positive result means that the drug concentration in the urine sample is greater
than the designated cut-off for a specific drug.
INVALID:Insufficient specimen volume or incorrect procedural techniques are the most likely
reasons for Control line failure. Read the directions again and repeat the test with a new test. If
the result is still invalid, contact your manufacturer.
【INTERPRETATION OF RESULTS (S.V.T/ ADULTERATION AND ALCOHOL)】
Results Example:
【QUALITY CONTROL】
A procedural control is included in the test. A line appearing in the control region (C) is
considered an internal procedural control. It confirms sufficient specimen volume, adequate
membrane wicking and correct procedural technique.
Control standards are not supplied with this kit. However, it is recommended that positive and
negative controls be tested as good laboratory practice to confirm the test procedure and to
verify proper test performance.
【LIMITATIONS】
1. The Multi-Drug Rapid Test provides only a qualitative, preliminary analytical result. A
secondary analytical method must be used to obtain a confirmed result. Gas
chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method.
2. There is a possibility that technical or procedural errors, as well as interfering substances in
the urine specimen may cause erroneous results.
3. Adulterants, such as bleach and/or alum, in urine specimens may produce erroneous results
regardless of the analytical method used. If adulteration is suspected, the test should be
repeated with another urine specimen.
4. A positive result does not indicate level or intoxication, administration route or concentration
in urine.
5. A negative result may not necessarily indicate drug-free urine. Negative results can be
obtained when drug is present but below the cut-off level of the test.
6. This test does not distinguish between drugs of abuse and certain medications.
7. A positive test result may be obtained from certain foods or food supplements.
【S.V.T/ADULTERATION LIMITATIONS】
1. The adulteration tests included with the product are meant to aid in the determination of
abnormal specimens. While comprehensive, these tests are not meant to be an “all-inclusive”
representation of possible adulterants.
2. Oxidants/PCC: Normal human urine should not contain oxidants or PCC. The presence of
high levels of antioxidants in the specimen, such as ascorbic acid, may result in false
negative results for the oxidants/PCC pad.
3. Specific Gravity: Elevated levels of protein in urine may cause abnormally high specific
gravity values.
4. Nitrite: Nitrite is not a normal component of human urine. However, nitrite found in urine may
indicate urinary tract infections or bacterial infections. Nitrite levels of > 20 mg/dL may
produce false positive glutaraldehyde results.
5. Glutaraldehyde: is not normally found in urine. However certain metabolic abnormalities such
as ketoacidosis (fasting, uncontrolled diabetes or high protein diets) may interfere with the
test results.
6. Creatinine: Normal Creatinine levels are between 20 and 350 mg/dL. Under rare conditions,
certain kidney diseases may show dilute urine.
7. Bleach: Normal human urine should not contain bleach. The presence of high levels of
bleach in the specimen may result in false negative results for the bleach pad.
【PERFORMANCE CHARACTERISTICS】
Accuracy
% Agreement with GC/MS
A study was conducted at three hospitals by laypersons using three different lots of product to
demonstrate the within run, between run and between operator precision. An identical card of
coded specimens, containing drugs at concentrations of negative, - 50% and 300% cut-off level,
was labeled, blinded and tested at each site. The results gained 100% accuracy in negative,
-50% and 300% cut-off level specimen.
A drug-free urine pool was spiked with drugs at the listed concentrations. The results are
summarized below.
4,5
Precision
Analytical Sensitivity
2/ 6

30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 +300% Cut-off
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + - + 0% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30 0 -50% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + 0% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 30 0 +300% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + 0% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 -50% Cut-off
30 0 30 0 29 1 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + -
30 0 30 0 30 0 30 0 30 0 30 0 30 0 -50% Cut-off
30 0 30 0 30 0 30 0 30 0 29 1 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + 0% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 -50% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + -
30 0 30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 30 0 +300% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + 0% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 -50% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 +300% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + -
30 0 30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 30 0 +300% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + -
30 0 30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 30 0 +300% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + - + 0% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + - + - + - + - + 0% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30 0 -50% Cut-off
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30
30 0 30 0 30 0 30 0 30 0 30 0 30 0 30
Drug
Concentration
Cut-off Range
- + - + - + - + 0% Cut-off
30 0 30 0 30 0 30 0 -50% Cut-off
ACETAMINOPHEN (ACE 5,000)
(±) 3,4-Methylenedioxy
amphetamine
(±) 3,4-Methylenedioxy
amphetamine
(±) 3,4-Methylenedioxy
amphetamine
BENZODIAZEPINES (BZO 500)
BENZODIAZEPINES (BZO 300)
BENZODIAZEPINES (BZO 200)
BENZODIAZEPINES (BZO 100)
Buprenorphine
3-D-Glucuronide
Norbuprenorphine
3-D-Glucuronide
Buprenorphine
3-D-Glucuronide
Norbuprenorphine
3-D-Glucuronide
The following table lists the concentrations of compounds (ng/mL) that are detected as positive
in urine by the Multi-Drug Rapid Test at 5 minutes.
Analytical Specificity
3/ 6

METHAMPHETAMINE (MET 1, 000)
()-3,4-Methylenedioxymethamphetamine
METHAMPHETAMINE (MET 500)
()-3,4-Methylenedioxymethamphetamine
METHAMPHETAMINE (MET 300)
()-3,4-Methylenedioxymethamphetamine
METHYLENEDIOXYMETHAMPHETAMINE (MDMA 1,000) Ecstasy
(±) 3,4-Methylenedioxy
methamphetamine HCl
3,4-Methylenedioxyethyl-amp
hetamine
(±) 3,4-Methylenedioxy
amphetamine HCl
METHYLENEDIOXYMETHAMPHETAMINE (MDMA 500) Ecstasy
(±) 3,4-Methylenedioxy
methamphetamine HCl
3,4-Methylenedioxyethyl-amp
hetamine
(±) 3,4-Methylenedioxy
amphetamine HCl
METHYLENEDIOXYMETHAMPHETAMINE (MDMA 300) Ecstasy
(±) 3,4-Methylenedioxy
methamphetamine HCl
3,4-Methylenedioxyethyl-amp
hetamine
(±) 3,4-Methylenedioxy
amphetamine HCl
Morphine-3-β-D-Glucuronide
MORPHINE/OPIATE (MOP/OPI 200)
Morphine-3-β-D-Glucuronide
Morphine-3-β-D-Glucuronide
MORPHINE/OPIATE (OPI 2,000)
Morphine 3--D-glucuronide
MORPHINE/OPIATE (OPI 1,000)
Morphine 3--D-glucuronide
TRICYCLIC ANTIDEPRESSANTS (TCA 1,000)
TRICYCLIC ANTIDEPRESSANTS (TCA 500)
TRICYCLIC ANTIDEPRESSANTS (TCA 300)
d,l-O-Desmethyl venlafaxine
d,l-O-Desmethyl venlafaxine
d,l-O-Desmethyl venlafaxine
d,l-O-Desmethyl venlafaxine
3,4-Methylendioxymethamphe
tamine (MDMA)
3,4-Methylendioxymethamphe
tamine (MDMA)
3,4-Methylendioxymethamphe
tamine (MDMA)
3,4-Methylendioxymethamphe
tamine (MDMA)
2-ETHYLIDENE-1,5-DIMETHYL-3,3-DIPHENYLPYRROLIDINE (EDDP 300)
2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)
2-ETHYLIDENE-1,5-DIMETHYL-3,3-DIPHENYLPYRROLIDINE (EDDP 100)
2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)
para-Fluorobutyryl fentanil
4-Fluoro-isobutyryl Fentanyl
para-Fluorobutyryl fentanil
4-Fluoro-isobutyryl Fentanyl
4/ 6

para-Fluorobutyryl fentanil
4-Fluoro-isobutyryl Fentanyl
para-Fluorobutyryl fentanil
4-Fluoro-isobutyryl Fentanyl
para-Fluorobutyryl fentanil
4-Fluoro-isobutyryl Fentanyl
SYNTHETIC MARIJUANA (K2-50)
SYNTHETIC MARIJUANA (K2-30)
SYNTHETIC MARIJUANA (K2-25)
6-MONO-ACETO-MORPHINE (6-MAM 10)
(±) 3, 4-METHYLENEDIOXYAMPHETAMINE (MDA 500)
(±) 3,4-Methylenedioxy
amphetamine
ETHYL- Β-D-GLUCURONIDE(ETG 500)
ETHYL- Β-D-GLUCURONIDE(ETG 1,000)
ETHYL- Β-D-GLUCURONIDE(ETG 300)
LYSERGIC ACID DIETHYLAMIDE (LSD 10)
Lysergic Acid Diethylamide
LYSERGIC ACID DIETHYLAMIDE (LSD 20)
Lysergic Acid Diethylamide
LYSERGIC ACID DIETHYLAMIDE (LSD 50)
Lysergic Acid Diethylamide
METHYLPHENIDATE (MPD 1,000)
Methylphenidate (Ritalin)
METHYLPHENIDATE (MPD 300)
Methylphenidate (Ritalin)
METHYLPHENIDATE (MPD 150)
Methylphenidate (Ritalin)
3-Fluoromethcathinone HCl
7-AMINOCLONAZEPAM(7-ACL 300)
7-AMINOCLONAZEPAM(7-ACL 200)
7-AMINOCLONAZEPAM(7-ACL 100)
(+)-Norpseudoephedrine HCl
(Cathine)
(+)3,4-Methylenedioxyamphet
amine (MDA)
3, 4-METHYLENEDIOXYPYROVALERONE (MDPV 1,000)
3, 4-methylenedioxy
pyrovalerone
3, 4-METHYLENEDIOXYPYROVALERONE (MDPV 500)
3, 4-methylenedioxy
pyrovalerone
3, 4-METHYLENEDIOXYPYROVALERONE (MDPV 300)
3, 4-methylenedioxy
pyrovalerone
3-Fluoromethcathinone HCl
4-Fluoromethcathinone HCl
3-Fluoromethcathinone HCl
4-Fluoromethcathinone HCl
AB-PINACA 5-hydroxypentyl
ADB-PINACA
N-(5-hydroxypentyl)
ADB-PINACA Pentanoic Acid
AB-PINACA 4-hydroxypentyl
5-fluoro AB-PINACA
N-(4-hydroxypentyl)
ALPHA-PYRROLIDINOVALEROPHENONE (Α-PVP 2,000)
alpha-Pyrrolidinovalerophenon
e
ALPHA-PYRROLIDINOVALEROPHENONE (Α-PVP 1,000)
alpha-Pyrrolidinovalerophenon
e
ALPHA-PYRROLIDINOVALEROPHENONE (Α-PVP 500)
alpha-Pyrrolidinovalerophenon
e
ALPHA-PYRROLIDINOVALEROPHENONE (Α-PVP 300)
alpha-Pyrrolidinovalerophenon
e
5-fluoro AB-Pinaca
N-(4-hydroxypentyl)
ADB-PINAC
N-(4-hydroxypentyl)
>10,000
UR-144 5-hydroxypentyl
AB-PINACA 4-hydroxypentyl
5/ 6

FLUOKETAMINE (FKET 1,000)
2-(2-fluorphenyl)-2-methylamin
o-cyclohexanone
3-((1R,2R)-3-(dimethylamino)-1
-ethyl-2-methylpropyl)phenol
N,N-DIMETHYLTRYPTAMINE(NND 1,000)
【ALCOHOL PERFORMANCE CHARACTERISTICS】
Reducing agents: Ascorbic acid, Tannic acid, Pyrogallol, Mercaptans and tosylates,
Oxalic acid, Uric Acid
Consult Instructions
For Use
Contains
sufficient for
<n> tests
Authorized
Representative
in the EU
In vitro
diagnostic medical
device
Temperature limit
2-30 °C
Do not use if package is
damaged
The detection limit on the Urine Alcohol Rapid Test is from 0.02% to 0.30% for approximate
relative blood alcohol level. The cutoff level of the Urine Alcohol Rapid Test can vary based on
local regulations and laws. Test results can be compared to reference levels with color chart on
the foil package.
【ALCOHOL ASSAY SPECIFICITY】
The Urine Alcohol Rapid Test will react with methyl, ethyl and allyl alcohols.
【ALCOHOL INTERFERING SUBSTANCES】
The following substances may interfere with the Urine Alcohol Rapid Test when using
samples other than urine. The named substances do not normally appear in sufficient quantity in
urine to interfere with the test.
A. Agents which enhance color development
B. Agents which inhibit color development
【BIBLIOGRAPHY】
1. B. Cody, J.T., “Specimen Adulteration in drug urinalysis. Forensic Sci. Rev., 1990, 2:63.
2. C. Tsai, S.C. et. al., J. Anal. Toxicol. 1998; 22 (6): 474
3. Tietz NW. Textbook of Clinical Chemistry. W.B. Saunders Company. 1986; 1735.
4. Hawks RL, CN Chiang. Urine Testing for Drugs of Abuse. National Institute for Drug Abuse
(NIDA), Research Monograph 73, 1986.
5. Baselt RC. Disposition of Toxic Drugs and Chemicals in Man. 6th Ed. Biomedical Publ.,
Foster City, CA 2002.
Index of Symbols
Fifteen (15) urine samples of normal, high, and low specific gravity ranges (1.005-1.045) were
spiked with drugs at 50% below and 50% above cut-off levels respectively. The Multi-Drug
Rapid Test was tested in duplicate using fifteen drug-free urine and spiked urine samples. The
results demonstrate that varying ranges of urinary specific gravity do not affect the test results.
The pH of an aliquoted negative urine pool was adjusted to a pH range of 5 to 9 in 1 pH unit
increments and spiked with drugs at 50% below and 50% above cut-off levels. The spiked,
pH-adjusted urine was tested with the Multi-Drug Rapid Test The results demonstrate that
varying ranges of pH do not interfere with the performance of the test.
A study was conducted to determine the cross-reactivity of the test with compounds in either
drug-free urine or drug positive urine containing above calibrator substances. The following
compounds show no cross-reactivity when tested with the Multi-Drug Rapid Test at a
concentration of 100 µg/mL.
Effect of Urinary Specific Gravity
Non Cross-Reacting Compounds
Effect of Urinary pH
Cross-Reactivity
6/ 6